Precision Medicine News and Research

RSS

AI-based technique determines cancer cells by their acidity

Healthy and cancer cells can look similar under a microscope. One way of differentiating them is by examining the level of acidity, or pH level, inside the cells.

17 Mar 2021

Machine learning approach can identify cancerous single cells by detecting its pH

Cancerous cells exhibit several key differences from healthy cells that help identify them as dangerous. For instance, the pH -- the level of acidity -- within a cancerous cell is not the same as the pH within a healthy cell.

16 Mar 2021

Scientists launch first educational curriculum in longevity medicine for physicians

Longevity medicine is a rapidly evolving branch of preventative precision medicine that is specifically focused on promoting healthspan and lifespan, utilizing aging biomarkers commonly referred to as aging clocks.

16 Mar 2021

Empiric Logic collaborates with UCD to develop novel genomics data protection methodology

Empiric Logic, an Irish bioinformatics SaaS (software-as-a-service) start-up, today announced that is has secured €85,000 in grant funding, under Enterprise Ireland's Innovation Partnership Programme, to develop a novel genomics data protection methodology in collaboration with University College Dublin.

15 Mar 2021

Immuno-PET detects changes in different cancer receptors in response to targeted therapies

Immuno-positron emission tomography (PET) imaging can provide early insight into a tumor's response to targeted therapy, allowing physicians to select the most effective treatment for patients who have cancer.

13 Mar 2021

Le Bonheur and UTHSC sign agreement to obtain genetic information from 25,000 DNA samples

As research into genetic causes of disease began to grow, Le Bonheur Pediatrician-in- Chief Jon McCullers, MD, knew it was time to start building a pediatric DNA biorepository.

13 Mar 2021

Random cellular changes play vital role in longevity beyond genetics and environment

A new model of aging takes into account not only genetics and environmental exposures but also the tiny changes that randomly arise at the cellular level.

13 Mar 2021

Henry Ford Cancer Institute launches new initiative to improve minority participation in clinical trials

Henry Ford Cancer Institute is launching the Participatory Action for Access to Clinical Trials (PAACT) project to dramatically improve the representation of the African American community and other minorities in cancer clinical trials.

11 Mar 2021

Study: Graphene nanoparticles interfere with the development of anxiety-related behaviors in vertebrates

New research shows that the nanomaterial acts on the excitatory synapses, interfering with the development of anxiety related behaviors in vertebrates.

11 Mar 2021

Organ-on-chip consortium receives huge grant to develop a universal standard for pharmaceutical industry

Scientists are pushing ahead building 'organ-on-chips', small chips with human cells, which are useful, for example, for studying cancerous metastases in the bloodstream or the development of scar tissue, or for testing the effect of drugs or food outside a human body.

10 Mar 2021

Phase 2 clinical trial is now open at Columbia to test gene therapy for dry macular degeneration

A phase 2 clinical trial is underway at Columbia University and NewYork-Presbyterian to test an investigational gene therapy for dry age-related macular degeneration, a progressive, chronic eye disease with no cure and a leading cause of blindness in the United States.

9 Mar 2021

New brain sensor could transform our understanding of Alzheimer’s

Scientists at the University of Virginia School of Medicine have developed a tool to monitor communications within the brain in a way never before possible, and it has already offered an explanation for why Alzheimer's drugs have limited effectiveness and why patients get much worse after going off of them.

9 Mar 2021

Scientists develop RNA-based therapeutic strategy for Charcot-Marie Tooth disease

Charcot-Marie Tooth disease is the most common hereditary neurological disease in the world. It affects the peripheral nerves and causes progressive paralysis of the legs and hands.

9 Mar 2021

Researchers establish organoid culture models from prostate tumor biopsies

Scientists at Urology Research Laboratory of the Department for BioMedical Research, University of Bern and Urology Department of the Inselspital of Bern, have established organoid culture models from prostate tumor biopsies.

8 Mar 2021

Interaction between LDL cholesterol and PRS can predict risk of heart attack

Allelica, a leading genomics software company specializing in developing polygenic risk scores (PRS) for personalised medicine, today announced publication of a study in Circulation (Vol. 143, Issue 10) showing that the effect of LDL cholesterol on a person's risk of having a heart attack depends on their genes.

8 Mar 2021

Using decision theory for precise choice of breast cancer treatment

The precise choice of treatment for breast cancer depends upon the status of the hormone receptors (for oestrogen and progesterone). Their conventional determination by means of immunohistochemistry (IHC) is associated with a certain error rate, which can be reduced by adding genomic data.

8 Mar 2021

Rare Disease Day: Illumina shines a spotlight on people living with rare diseases

With a mission of empowering the rare disease community, Illumina has today partnered with medical researchers and families to highlight the importance of genomic sequencing and to shine the spotlight on the 300 million people worldwide living with a rare disease.

8 Mar 2021

Artificial intelligence can predict risk of new-onset atrial fibrillation and AF-related stroke

A team of scientists from Geisinger and Tempus have found that artificial intelligence can predict risk of new atrial fibrillation (AF) and AF-related stroke.

5 Mar 2021

New approach using virtual clinical trials could revolutionize drug development

New cutting-edge research undertaken at the University of Leicester could revolutionize the way new drugs are developed and the way patients are cared for, through a pioneering new approach using virtual clinical trials

5 Mar 2021

Emerging protein-based immunotherapies could lead to highly effective cancer treatments

In a new commentary for the journal Science, an associate vice president for research at The University of Texas at Arlington argues that emerging protein-based immunotherapies could lead to highly effective "off-the-shelf" cancer treatments for more patients.

1 Mar 2021

Precision Medicine News and Research

AI-based technique determines cancer cells by their acidity

Machine learning approach can identify cancerous single cells by detecting its pH

Scientists launch first educational curriculum in longevity medicine for physicians

Empiric Logic collaborates with UCD to develop novel genomics data protection methodology

Immuno-PET detects changes in different cancer receptors in response to targeted therapies

Le Bonheur and UTHSC sign agreement to obtain genetic information from 25,000 DNA samples

Random cellular changes play vital role in longevity beyond genetics and environment

Henry Ford Cancer Institute launches new initiative to improve minority participation in clinical trials

Study: Graphene nanoparticles interfere with the development of anxiety-related behaviors in vertebrates

Organ-on-chip consortium receives huge grant to develop a universal standard for pharmaceutical industry

Phase 2 clinical trial is now open at Columbia to test gene therapy for dry macular degeneration

New brain sensor could transform our understanding of Alzheimer’s

Scientists develop RNA-based therapeutic strategy for Charcot-Marie Tooth disease

Researchers establish organoid culture models from prostate tumor biopsies

Interaction between LDL cholesterol and PRS can predict risk of heart attack

Using decision theory for precise choice of breast cancer treatment

Rare Disease Day: Illumina shines a spotlight on people living with rare diseases

Artificial intelligence can predict risk of new-onset atrial fibrillation and AF-related stroke

New approach using virtual clinical trials could revolutionize drug development

Emerging protein-based immunotherapies could lead to highly effective cancer treatments

Editorial Focus eBook - Proteomics eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News